Form 4 for SPRY ARS Pharmaceuticals, Inc.
Accepted 2024-04-22 00:00:00 ET · period of report 2024-04-19 · accession 0001415889-24-011335 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-04-22 | 2024-04-19 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | M - OptEx | $1.06 | +188.5K | 4.25M | +5% | +$200.0K |
| DMI | 2024-04-22 | 2024-04-19 | SPRY | Tanimoto Sarina | Chief MEDICAL Off, 10% | M - OptEx | $0.00 | -188.5K | 166.9K | -53% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-19 | M | A | 69,444 | $1.44 | 4,315,313 | I By Spouse | — | — | |
| 2 | Common | Common Stock | 2024-04-19 | M | A | 119,047 | $0.84 | 4,245,869 | I By Spouse | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2024-04-19 | M | D | 119,047 | $0.00 | 117,333 | I By Spouse | $0.84 · — to 2029-12-16 | 119,047 Common Stock | (F4) 25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date. |
| 4 | Derivative | Stock Option (right to buy) | 2024-04-19 | M | D | 69,444 | $0.00 | 166,936 | I By Spouse | $1.44 · — to 2031-12-13 | 69,444 Common Stock | (F4) 25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date. |